Literature DB >> 28138749

The relationship between postmenopausal women's sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products.

Muberra Namlı Kalem1, Ziya Kalem2, Nilufer Akgun3, Batuhan Bakırarar4.   

Abstract

PURPOSE: To investigate the relationship between postmenopausal women's sclerostin levels and bone density and the factors that may affect this relationship.
MATERIALS AND METHODS: 135 postmenopausal patients' ages, BMIs, hormonal statuses, BMD values, and smoking, and consumption of coffee and dairy products were compared with their sclerostin levels.
RESULTS: No statistical relationship was found between sclerostin level and age in the group with osteoporosis (p = 0.204, r = -0.305). There was a positive, high-level relationship between sclerostin levels and BMI in the osteoporosis group and it was found to be statistically significant (p < 0.001, r = 0.786). No statistical relationship was found between sclerostin level and age in the non-osteoporosis group with (p = 0.496, r = -0.88). There was a positive, moderate relationship between sclerostin levels and BMI in the non-osteoporosis group and it was found to be statistically significant (p < 0.001, r = 0.505). No statistically significant relationship could be found between sclerostin levels and vitamin D (p = 0.723), PTH (p = 0.112), FSH (p = 0.795), E2 (p = 0.627), TSH (p = 0.517), T3 (p = 0.788), and T4 (p = 0.664) blood levels. No significant difference was found among the groups formed by smoking, consumption of coffee and milk, and dairy products, either (p = 0.405; p = 0.626; p = 0.234, respectively). It was monitored that sclerostin's negative effect observed on BMD scores was independent from age; however, it had a positive correlation with BMI.
CONCLUSION: As blood sclerostin levels increase, bone mineral density decreases. This negative effect of sclerostin on bone density increases as BMI increases, too. Effects of sclerostin levels on bone density are independent from age, and they are not affect by levels of vitamin D: PTH, FSH, E2 and thyroid hormones, and daily activities, such as smoking and consumption of coffee and milk and dairy products, either.

Entities:  

Keywords:  Body mass index; Bone mineral density; Coffee; Dairy products; Sclerostin; Smoking

Mesh:

Substances:

Year:  2017        PMID: 28138749     DOI: 10.1007/s00404-017-4288-x

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  6 in total

1.  Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis.

Authors:  Jia Peng; Zhang Dong; Zhang Hui; Wang Aifei; Deng Lianfu; Xu Youjia
Journal:  BMC Musculoskelet Disord       Date:  2021-05-25       Impact factor: 2.362

2.  Associations between Dietary Fiber Intake and Bone Mineral Density in Adult Korean Population: Analysis of National Health and Nutrition Examination Survey in 2011.

Authors:  Taehoon Lee; Heuy Sun Suh
Journal:  J Bone Metab       Date:  2019-08-31

3.  Romosozumab: a novel bone anabolic treatment option for osteoporosis?

Authors:  Katharina Kerschan-Schindl
Journal:  Wien Med Wochenschr       Date:  2019-12-19

4.  Assessment of Sclerostin and Interleukin 6 Levels and Selected Anthropometric Parameters in Patients Receiving Hemodialysis Replacement Therapy-Pilot Study.

Authors:  Agnieszka Turon-Skrzypinska; Grazyna Dutkiewicz; Malgorzata Marchelek-Mysliwiec; Violetta Dziedziejko; Kazimierz Ciechanowski; Aleksandra Ryl; Iwona Rotter
Journal:  Medicina (Kaunas)       Date:  2019-12-15       Impact factor: 2.430

5.  Type 2 diabetes affects bone cells precursors and bone turnover.

Authors:  Francesca Sassi; Ilaria Buondonno; Chiara Luppi; Elena Spertino; Emanuela Stratta; Marco Di Stefano; Marco Ravazzoli; Gianluca Isaia; Marina Trento; Pietro Passera; Massimo Porta; Giovanni Carlo Isaia; Patrizia D'Amelio
Journal:  BMC Endocr Disord       Date:  2018-08-08       Impact factor: 2.763

6.  Circulating bioactive sclerostin levels in an Austrian population-based cohort.

Authors:  Katharina Kerschan-Schindl; Ursula Föger-Samwald; Andreas Gleiss; Stefan Kudlacek; Jacqueline Wallwitz; Peter Pietschmann
Journal:  Wien Klin Wochenschr       Date:  2021-02-05       Impact factor: 1.704

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.